feed,title,long_url,short_url
Benzinga,"Neurocrine Biosciences Clocks 35% Revenue Growth In Q1, Misses On Bottom-Line Performance",https://benzinga.com/news/earnings/23/05/32192861/neurocrine-biosciences-clocks-35-revenue-growth-in-q1-misses-on-bottom-line-performance,https://da.gd/zX3hr1
